New gene technology is able to predict the effect of treatment on the individual breast cancer patient How do you know whether breast cancer treatment will be able to cure the individual patient? New gene technology can tell us, and it may prove vital to patients.
All project plans are valid for two years after which they must be renewed All project plans beginning with a P- or A-number lower than these will be invalid, which means that you cannot order animals or begin a new experiment. Therefore, if your project plan will or has expired, you need to…
Major discovery about mammalian brains surprises researchers In a new breakthrough to understand more about the mammalian brain, University of Copenhagen researchers have made an incredible discovery. Namely, a vital enzyme that enables brain signals is switching on and off at…
Seminar on Current Regulatory Actions Addressing Pharmaceuticals in the Environment was held on Nov 3, 2022 in Helsinki A hybrid seminar on Current Regulatory Actions Addressing Pharmaceuticals in the Environment was hosted by the University of Helsinki on November 3, 2022. The seminar gathered together ca. 40 participants live in…
A new workshop on physiologically based pharmacokinetic modeling well received A new workshop on physiologically based pharmacokinetic modeling was organised at the University of Eastern Finland recently, with the internationally invited lecturers Professor Leon Aarons from the University of…
Stem cell therapy for Parkinson’s Disease granted approval for entering clinical trial in Sweden Associate Professor and Principal Investigator from reNEW UCPH brings hope to people with Parkinson’s Disease by being part of a decade long team effort between universities and hospitals in Sweden and the UK.
Excessive brain fluid can lead to risky surgery. New research seeks to change that Researchers from the University of Copenhagen have discovered that fluid does not necessarily enter the brain the way one thought. According to one of the researchers behind the study, the result may lead to fewer major…
Translational AML trial improves clinical outcome and identifies novel drugs for future treatment The LD-VenEx trial exemplifies the vast potential of clinical trials integrating translational research programs, says research group leader Kim Theilgaard-Mönch. In a large investigator-initiated trial, clinicians form…
Five SUND-researchers get DKK 42 million to exciting projects Five researchers from the Faculty of Health and Medical Sciences receive big grants from the Novo Nordisk Foundation.
Major investment for developing Denmark’s first fully functional quantum computer Denmark’s first fully functional generally applicable quantum computer will be available in 2034. This is the objective of the ambitious Novo Nordisk Foundation Quantum Computing Programme that is being launched in…
Major investment for developing Denmark’s first fully functional quantum computer Denmark’s first fully functional generally applicable quantum computer will be available in 2034. This is the objective of the ambitious Novo Nordisk Foundation Quantum Computing Programme that is being launched in…
“Extremely satisfying” as researchers find new hope for heart patients There is currently no cure for the heart condition ARVC, which usually affects young individuals. A new study from the University of Copenhagen presents a surprising new treatment strategy.
“Extremely satisfying” as researchers find new hope for heart patients There is currently no cure for the heart condition ARVC, which usually affects young individuals. A new study from the University of Copenhagen presents a surprising new treatment strategy.
Global health summer courses: 150 students are ready to tackle future global health challenges Over three weeks, 150 students from more than 20 different countries have participated in School of Global Health's summer courses
New gene technology can reveal how well medicine works. Behind it, you will find the new company BioPhenyx Researchers from the University of Copenhagen have started a new company which, on the basis of gene technology, shall make the development of medicine faster and more precise. According to the researchers behind the…
Researchers crack the code to muscle generation In a new study, researchers from the University of Copenhagen have identified a protein that the body uses to generate muscle mass and have even succeeded in artificially triggering it.
Rationale for combination therapy in acute myeloid leukemia Acute myeloid leukemia (AML) is a highly heterogeneous disease for which there is an unmet need for improved targeted therapies. In a new study, the Olsen Group and collaborators use phosphoproteomics to devise rational…
Phages to fight bacterial infections A team of researchers from England, Scotland, Norway, and Denmark have joined forces to develop a safe and efficient phage therapy approach to control the bacteria Pasteurella in Atlantic Salmon farms.
“You have a new match!” The “PerMed Match-Making Day” of the Personalised Medicine Research Cluster was a great success, and will likely be the beginning of many new matches between researchers.
Revolutionary tool could meet future pandemics with accelerated response A new tool speeds up development of vaccines and other pharmaceutical products by more than one million times while minimizing costs.
The abstracts submitted for the Annual Meeting 2022 may be updated Due to changes in date of the Annual Meeting 2022, rescheduled to August 10-12, 2022, the abstracts that were submitted under the registration period may be updated. Since the Annual Meeting was shifted by 6 months, the…
Fruit fly metabolism could pave the way for new obesity and diabetes drugs The inner workings of fruit flies are more similar to those of humans than one might think. Now, researchers from the University of Copenhagen have discovered a hormone in these flies that can help us better understand…
CANCELLATION OF 1st Joint Symposium of China's Pharmaceutical Association and Nordic POP The event planned for this summer in Shenyang university had to be cancelled due to ongoing pandemic situation. The 14th China Pharmaceutics Conference should include the first joint event of China's Pharmaceutical…
Covid-19 clinical trials ignore gender differences Although the coronavirus affects men and women differently, most clinical trials do not mention sex/gender, a new analysis of 4,420 studies concludes. Ultimately, it can influence the treatment negatively.